Metformina Teva (Metformin Hydrochloride)

Metformin acts mainly by inhibiting hepatic gluconeogenesis, which reduces the amount of glucose released into the bloodstream. It also increases peripheral insulin sensitivity, enhancing glucose uptake in muscle and adipose tissue, and modestly decreases intestinal absorption of glucose. These combined actions lead to lower fasting and post‑prandial blood glucose levels.

The dosage of Metformina Teva is individualized by the prescribing healthcare professional based on the patient’s renal function, glycaemic targets, and tolerability. Typically, treatment starts with a low dose that is gradually increased, but the exact amount and frequency must be determined by the prescriber.

Metformina Teva is classified as pregnancy category unknown, but it is generally used only when the potential benefit outweighs potential risks. Limited data suggest it can be continued in pregnancy for women with type 2 diabetes under specialist supervision. It is excreted in breast milk in small amounts, so a risk‑benefit assessment is required before use while nursing.

To request Metformina Teva, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature requirements) and the necessary import documentation.

Compared with sulfonylureas, metformin (Metformina Teva) does not stimulate insulin secretion, so it carries a lower risk of hypoglycaemia. Unlike insulin, it is taken orally and does not require injection. Its weight‑neutral or modest weight‑loss effect contrasts with the weight gain often seen with thiazolidinediones. Overall, metformin is considered first‑line therapy for type 2 diabetes.

Metformina Teva tablets should be stored at ambient temperature, below 25 °C (77 °F). Keep them in the original blister or container, protect from moisture, heat and direct sunlight. Do not store in bathrooms or near kitchen appliances, and keep out of reach of children.

Metformina Teva is taken by mouth, usually with meals to reduce gastrointestinal discomfort. The tablets should be swallowed whole with a full glass of water and not chewed or crushed unless specifically instructed by a healthcare professional. Consistent timing with respect to meals helps maintain stable drug absorption.

The most serious adverse reaction is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, excessive alcohol intake, or acute cardiovascular events. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, abdominal discomfort, or unexplained fatigue develop.

Metformina Teva is contraindicated in patients with known hypersensitivity to metformin or any component of the formulation, in those with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in patients receiving iodinated contrast studies until renal function is re‑evaluated.